Skip to main content
. 2024 Jan 4;221(2):e20231353. doi: 10.1084/jem.20231353

Table 1.

Auto-Abs neutralized by the serum from the 19 patients

Patient Anti-IFN-α2 auto-Abs (10 ng/ml) Anti-IFN-β auto-Abs (10 ng/ml) Anti-IFN-ω auto-Abs (10 ng/ml) Anti-IFN-α2 auto-Abs (100 pg/ml) Anti-IFN-ω auto-Abs (100 pg/ml)
P1 1 0 0 1 0
P2 1 1 1 1 1
P3 0 0 0 1 0
P4 0 0 0 0 1
P5 0 0 0 0 1
P6 0 0 0 0 1
P7 0 0 0 1 1
P8 1 0 1 1 1
P9 1 0 1 1 1
P10 0 0 0 1 0
P11 0 0 0 1 1
P12 1 0 0 1 1
P13 0 0 0 0 1
P14 1 1 1 1 1
P15 0 0 0 0 1
P16 0 0 1 0 1
P17 0 0 0 0 1
P18 0 0 0 0 1
P19 0 0 0 0 1

1: neutralizing. 0: non-neutralizing.